News Releases
January 26, 2012
Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America
(read more)
January 3, 2012
Stellar Pharmaceuticals Hires New VP of Sales
(read more)
January 3, 2012
Apricus Biosciences and Stellar Pharmaceuticals Announce Exclusive License Agreement in Canada for the Commercialization of MycoVa(TM) for Onychomycosis
(read more)
January 3, 2012
Stellar Pharmaceuticals Inc.: Conference Call
(read more)
December 1, 2011
Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American Specialty Pharmaceutical Company
(read more)
November 14, 2011
Stellar Pharmaceuticals Reports Third Quarter 2011 Financial Results
(read more)
September 13, 2011
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
(read more)
August 17, 2011
Stellar Pharmaceuticals Issued Uracyst(R) Patent in Japan
(read more)
August 15, 2011
Stellar Pharmaceuticals Reports Second Quarter 2011 Financial Results
(read more)
June 8, 2011
Stellar Pharmaceuticals Engages Advisory Consultant for Its Products in the United States Market
(read more)
May 16, 2011
Stellar Pharmaceuticals Reports First Quarter 2011 Financial Results
(read more)
April 13, 2011
Stellar Pharmaceuticals Inc. and Watson Pharmaceuticals, Inc. Terminate Uracyst(R) Supply and Licensing Agreements
(read more)
March 31, 2011
Stellar Pharmaceuticals Profitable for 2010; Revenues Up 32% & Net Profit Up 120%
(read more)
March 15, 2011
Stellar Pharmaceuticals Engages Seasoned Business Development Consultant
(read more)
March 7, 2011
Stellar's Common Shares Now Trading on OTCQB
(read more)
January 18, 2011
Stellar Pharmaceuticals Announces Retirement of Peter Riehl as CEO, President and Director
(read more)
January 6, 2011
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
(read more)
November 16, 2010
Stellar Pharmaceuticals Provides Further Update on the Watson Ur008 Pilot Study of Uracyst(R)
(read more)
November 10, 2010
Stellar Pharmaceuticals Provides Update on Watson's U.S. Pilot Study of Uracyst(R)
(read more)
November 9, 2010
Stellar Pharmaceuticals Reports Third Quarter 2010 Financial Results
(read more)
October 11, 2010
Stellar Pharmaceuticals Announces Completion of Non-Brokered Private Placement
(read more)
October 5, 2010
Stellar Pharmaceuticals Announces Non-Brokered Private Placement
(read more)
August 11, 2010
Stellar Pharmaceuticals Inc. to Present at Global Hunter Investor Conference
(read more)
August 6, 2010
Stellar Pharmaceuticals Reports Second Quarter 2010 Financial Results
(read more)
July 30, 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
(read more)
July 28, 2010
Stellar Pharmaceuticals Issued Uracyst(R) Patents in the United States and China
(read more)
June 23, 2010
Stellar Pharmaceuticals Allowed Uracyst(R) Patent in United States of America
(read more)
May 14, 2010
Stellar Pharmaceuticals Reports First Quarter 2010 Financial Results
(read more)
May 6, 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Germany and Austria
(read more)
May 5, 2010
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
(read more)
April 9, 2010
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
(read more)
March 17, 2010
Stellar Pharmaceuticals Profitable for 2009
(read more)
March 8, 2010
Stellar Pharmaceuticals Allowed Uracyst(R) Patent in China
(read more)
February 23, 2010
Stellar Pharmaceuticals to Present at the Cowen & Company 30th Annual Healthcare Conference
(read more)
November 10, 2009
CORRECTION FROM SOURCE: Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability
(read more)
November 6, 2009
Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability
(read more)
October 26, 2009
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution And Sale of Uracyst(R) in South Korea
(read more)
October 15, 2009
Stellar Pharmaceuticals' Uracyst(R) the Subject of Positive Presentation at Major Urology Conference
(read more)
September 1, 2009
Stellar Pharmaceuticals Retains Kilmer Lucas for Investor Communications
(read more)
August 5, 2009
Stellar Pharmaceuticals Announces Record Second Quarter Revenues and Profitability for the First Half
(read more)
August 4, 2009
Stellar Pharmaceuticals to Host Second Quarter 2009 Earnings Conference Call
(read more)
June 19, 2009
Stellar Pharmaceuticals Provides Guidance for 2009 Second Quarter Revenues in Excess of One Million Dollars (CDN)
(read more)
June 18, 2009
Stellar Pharmaceuticals Announces the Launch of Neovisc(R) Single Dose
(read more)
June 10, 2009
Stellar Pharmaceuticals Inc. Announces Watson Pharma, Inc. Has Received a Conditional IDE Approval for Stellar's Uracyst(R) From the FDA
(read more)
June 4, 2009
Stellar Pharmaceuticals Announces Record First Quarter Financial Results and Profitability
(read more)
May 20, 2009
Stellar Pharmaceuticals Announces a Late Filing of First Quarter Financial Results Due to Change in Auditors
(read more)
May 5, 2009
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
(read more)
April 22, 2009
Stellar Pharmaceuticals Inc. Announces Mr. Martin Thrasher has Joined Their Board of Directors
(read more)
April 13, 2009
Stellar Pharmaceuticals Cash Positive for 2008
(read more)
April 9, 2009
Stellar Pharmaceuticals Inc. Announces Normal Course Issuer Bid
(read more)
February 9, 2009
Stellar Pharmaceuticals to Present at 2009 Equities Conference and Provides International Uracyst(R) Sales Update
(read more)
January 8, 2009
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Netherlands, Belgium and Luxemburg
(read more)
December 10, 2008
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Sweden, Denmark, Finland, Norway and Iceland
(read more)
December 9, 2008
Stellar Pharmaceuticals Inc. Signs Licensing Agreement For Distribution and Sale of Uracyst(R) in United Kingdom and Ireland
(read more)
November 13, 2008
Stellar Pharmaceuticals Inc. Announces Product Revenue Increases for Both Domestic and International Markets
(read more)
October 24, 2008
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Turkey
(read more)
August 18, 2008
Stellar Pharmaceuticals Inc. Announces Successful Completion of Watson's Pilot Clinical Study
(read more)
August 12, 2008
Stellar Pharmaceuticals Inc. Announces Revenues Increased by 20.7% Gross Profits Up By 29.2%
(read more)
June 9, 2008
Stellar Pharmaceuticals Inc. Announces its Decision to Voluntary Delist From TSX Venture Exchange
(read more)
May 15, 2008
Stellar Pharmaceuticals Inc. Announces Revenue Increased by 25.7% Gross Profits up by 50.9%
(read more)
May 12, 2008
Stellar Pharmaceuticals Inc. Provides Update on Normal Course Issuer Bid & Provides Company Updates
(read more)
April 7, 2008
CORRECTION FROM SOURCE: Stellar Pharmaceuticals Inc. Announces Stock Buyback Program
(read more)
April 7, 2008
Stellar Pharmaceuticals Inc. Announces Stock Buyback Program
(read more)
March 31, 2008
Stellar Pharmaceuticals Announces Profitability for 2007 Fourth Quarter
(read more)
March 18, 2008
Stellar Pharmaceuticals Inc. Announces the Receipt Of Their First Order for Neovisc(R) Going to Torrex Chiesi Pharma GmbH
(read more)
November 14, 2007
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of NeoVisc(R) in Eastern Europe
(read more)
November 8, 2007
Stellar Pharmaceuticals Announces Profitability for 2007 Third Quarter Financial Results
(read more)
October 4, 2007
Stellar Pharmaceuticals Provides Strong 3rd Quarter Guidance
(read more)
September 25, 2007
Stellar Pharmaceuticals Reports the Purchase of Stellar Shares in the Open Market by CEO and CFO
(read more)
September 11, 2007
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
(read more)
August 15, 2007
Stellar Pharmaceuticals Announces 2007 Second Quarter Financial Results and Uracyst(R) Updates
(read more)
August 14, 2007
Stellar Pharmaceuticals Schedules Second Quarter 2007 Financial Results and Conference Call
(read more)
June 22, 2007
Stellar Pharmaceuticals Inc. Holds Annual Shareholder Meeting
(read more)
June 7, 2007
Stellar Pharmaceuticals Retains Investment Banking Firm Ladenburg Thalmann
(read more)
May 11, 2007
Stellar Pharmaceuticals Announces 2007 First Quarter Financial Results
(read more)
May 8, 2007
Stellar Pharmaceuticals Schedules First Quarter 2007 Financial Results and Conference Call
(read more)
March 30, 2007
CORRECTION FROM SOURCE: Stellar Pharmaceuticals Announces 2006 Fourth Quarter and Year-End Financial Results
(read more)
March 30, 2007
Stellar Pharmaceuticals Announces 2006 Fourth Quarter and Year-End Financial Results
(read more)
March 28, 2007
Stellar Pharmaceuticals Schedules Fourth Quarter and Year End Financial Results and Conference Call
(read more)
February 26, 2007
Stellar Pharmaceuticals Announces John Gregory Founder of King Pharma and Stellar's Largest Shareholder Has Joined the Board of Directors
(read more)
December 27, 2006
Stellar Pharmaceuticals Retains Investor Relations Firm
(read more)
December 22, 2006
Stellar Pharmaceuticals Achieves Profitability for 2006
(read more)
December 14, 2006
Stellar Pharmaceuticals Signs License and Supply Agreements With Watson Pharmaceuticals for Stellar's Uracyst'R' Product
(read more)
November 9, 2006
Stellar Pharmaceuticals Announces 2006 Third Quarter Financial Results
(read more)
November 2, 2006
Stellar Pharmaceuticals Schedules Third Quarter Financial Results and Conference Call
(read more)
August 30, 2006
Stellar Pharmaceuticals Receives CE Mark For NeoVisc'R'
(read more)
August 10, 2006
Stellar Pharmaceuticals Announces 2006 Second Quarter Financial Results
(read more)
August 9, 2006
Stellar Pharmaceuticals Schedules Second Quarter Financial Results and Conference Call
(read more)
July 13, 2006
Stellar Pharmaceuticals & Bio-Technic Sign Licensing Agreement for Neovisc'R' in Romania
(read more)
May 11, 2006
Stellar Pharmaceuticals Announces 2006 First Quarter Financial Results
(read more)
May 8, 2006
Stellar Pharmaceuticals Schedules First Quarter Financial Results and Conference Call
(read more)
April 10, 2006
Stellar Pharmaceuticals Announces Presentation of NMP22'R' BladderChek'R' Test at The 21st Annual Congress of The European Association of Urology
(read more)
March 31, 2006
Stellar Pharmaceuticals Announces 2005 Fourth Quarter and Year End Financial Results
(read more)
March 28, 2006
Stellar Pharmaceuticals Reschedules Fourth Quarter and Year End Financial Results and Conference Call
(read more)
March 23, 2006
Stellar Pharmaceuticals Announces the Successful Completion of a Quality Management System Upgrade
(read more)
March 22, 2006
Stellar Pharmaceuticals Schedules Fourth Quarter and Year End Financial Results and Conference Call
(read more)
January 25, 2006
Stellar Pharmaceuticals to Present at Brean Murray, Carret & Co. Small Cap Institutional Investor Conference
(read more)
January 10, 2006
Stellar Pharmaceuticals and Al-Mohab Trading & Contracting Company Sign Licensing Agreement for NeoVisc'R' in Kuwait
(read more)
December 22, 2005
CORRECTION FROM SOURCE: Stellar Pharmaceuticals Inc. Reports Grant Of Options To Officers And Directors
(read more)
December 22, 2005
Stellar Pharmaceuticals Inc. Reports Grant Of Options To Officers And Directors
(read more)
December 20, 2005
Stellar Pharmaceuticals and Megapharm Sign Licensing Agreement for Uracyst'R' in Israel
(read more)
November 11, 2005
Stellar Re-files Annual and Interim CEO and CFO Certifications
(read more)
November 10, 2005
Stellar Pharmaceuticals Reports Third Quarter Financial Results
(read more)
November 7, 2005
Stellar Pharmaceuticals Schedules Third Quarter Financial Results And Conference Call
(read more)
October 21, 2005
Stellar Pharmaceuticals Named to 2005 Deloitte Technology Fast 500 List
(read more)
October 13, 2005
Stellar Pharmaceuticals Launches a Higher Molecular Weight Hyaluronate Formulation for NeoVisc'R'
(read more)
September 29, 2005
CORRECTION FROM SOURCE: Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Uracyst'R' In China
(read more)
September 29, 2005
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Uracyst'R' In China
(read more)
August 22, 2005
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of NeoVisc'R' in Lebanon and Syria
(read more)
August 12, 2005
Stellar Pharmaceuticals Inc. Retains Basic Investors, Inc.
(read more)
August 11, 2005
Stellar Pharmaceuticals Announces 2005 Second Quarter Financial Results
(read more)
August 8, 2005
Stellar Pharmaceuticals Schedules Second Quarter Financial Results and Conference Call
(read more)
July 15, 2005
Stellar Pharmaceuticals Inc. Names Patrick Scrivens as Advisor
(read more)
July 14, 2005
Stellar Pharmaceuticals Inc. and InnoGen Ltd. Sign NeoVisc'R' Licensing Agreement for Turkey
(read more)
June 8, 2005
CORRECTION FROM SOURCE: Stellar Pharmaceuticals Inc. Nominates Medical Device Industry Veteran Robert H. Kayser for Election to Board of Directors
(read more)
June 7, 2005
Stellar Pharmaceuticals Inc. Nominates Medical Device Industry Veteran Robert H. Kayser for Election to Board of Directors
(read more)
May 13, 2005
Stellar Pharmaceuticals Inc. Reports Grant of Options to Officers and Directors
(read more)
May 11, 2005
Stellar Pharmaceuticals Inc. Announces 2005 First Quarter Financial Results
(read more)
May 9, 2005
Stellar Pharmaceuticals Schedules First Quarter Financial Results And Conference Call
(read more)
May 9, 2005
Stellar Pharmaceuticals Inc. Announces Launch of Uracyst in the United Kingdom
(read more)
March 31, 2005
Stellar Pharmaceuticals Announces 2004 Financial Results
(read more)
March 29, 2005
Stellar Pharmaceuticals Schedules Fourth Quarter And Year-End Financial Results And Conference Call
(read more)
February 22, 2005
Stellar Pharmaceuticals Inc.: Journal of the American Medical Association Reports NMP22 BladderChek Test Detects Bladder Cancers Missed by Cystoscopy
(read more)
January 7, 2005
Stellar Pharmaceuticals Inc. Appoints Investor Relations Firms
(read more)
January 4, 2005
Stellar International Inc. Changes Name to Stellar Pharmaceuticals Inc.
(read more)
December 3, 2004
Stellar International Inc. Reports Grant of Options to Investor Relations Firms
(read more)
November 15, 2004
CORRECTION FROM SOURCE: Stellar International Reports Continued Revenue Growth for Third Quarter and Nine Months
(read more)
November 15, 2004
Stellar International Reports Continued Revenue Growth for Third Quarter and Nine Months
(read more)
November 10, 2004
Stellar International Announces Date of its 3Q'04 Results Release and Conference Call
(read more)
November 1, 2004
Stellar International Inc. Launches Sales Of NMP22'R' BladderChek'R' In Canada
(read more)
October 8, 2004
Stellar International To Present At Healthpoint Capital's Biomaterials Summit In New York
(read more)
October 7, 2004
Statement By Stellar International Inc.
(read more)
September 20, 2004
Stellar International Inc. Receives Approval From Health Canada to Market NMP22'R' BladderChek'R' for the Diagnosis and Monitoring of Bladder Cancer
(read more)
September 9, 2004
Stellar International Inc. and Tripti Bumis Sdn. Bhd. Sign Neovisc'R' Licensing Agreement for Malaysia, Singapore and Brunei
(read more)
August 18, 2004
Stellar International Inc Enters into Licensing Agreement with Pharmore GmbH for NeoVisc 'R' in Germany
(read more)
August 16, 2004
Stellar International Reports Second Quarter Results
(read more)
August 9, 2004
Stellar International Announces Date Of Its Second-Quarter 2004 Results Release And Conference Call
(read more)
August 9, 2004
Stellar International Broadens its Distribution Network for NeoVisc'R'
(read more)
July 15, 2004
Stellar International Inc. Appoints Arnold S. Tenney As Chairman Of The Board
(read more)
July 15, 2004
Statement by Stellar International
(read more)
June 24, 2004
Stellar International Inc. Expanding From Medical Devices To Pharmaceutical Products
(read more)
May 25, 2004
Stellar International Inc Moves Its Manufacturing To Dalton Chemicals Laboratories Inc
(read more)
May 19, 2004
Stellar International Announces First Quarter 2004 Results; Revenue and Margins Climb, Loss Drops (US DOLLARS/USGAAP)
(read more)
May 13, 2004
Stellar International Announces Date Of Its First Quarter 2004 Results Release And Conference Call
(read more)
April 22, 2004
Stellar International Inc. Selects Allen & Caron for Corporate Communications, Investor and Media Relations
(read more)
April 14, 2004
CORRECTION FROM SOURCE: Stellar International Inc. Reports Revenue Growth Of 29.8% For The Year Ended December 31, 2003
(read more)
April 13, 2004
Stellar International Inc. Reports Revenue Growth Of 29.8% For The Year Ended December 31, 2003
(read more)
April 2, 2004
Stellar International Inc. Reports Grant of Options to Directors
(read more)
March 25, 2004
Stellar International Inc. Signs Supply and Out-License Agreements for NeoVisc(R) and Uracyst(R) with SJ Pharmaceuticals Inc. for the United States Market.
(read more)
March 1, 2004
Stellar International Participates in Broadcast Interviews with CEOCast and the Wall Street Reporter
(read more)
February 19, 2004
Stellar International Inc. and SJ Strategic Investments LLC Announce Private Placement of Over 4 Million Common Shares of Stellar to SJ
(read more)
January 29, 2004
Stellar International Inc. Launches Skelite In Canada
(read more)
January 21, 2004
Stellar Retains Consultant
(read more)
January 6, 2004
Stellar International Inc. Moves to Tier 2 of the TSX Venture Exchange and Receives New Trading Symbol
(read more)
December 22, 2003
Stellar International Receives Second Milestone Payment for the European Market
(read more)
December 1, 2003
Stellar International's Uracyst(R)-S is Launched in Europe
(read more)
November 19, 2003
Stellar Announces Grant of Options
(read more)
November 17, 2003
Stellar International Reports Continued Revenue Growth For Third Quarter And Nine Months
(read more)
January 11, 2002
Stellar International Inc. Announces First Licensing Agreement
(read more)
July 26, 2001
Stellar International Reports Second Quarter & First Half Revenue Gains
(read more)
June 7, 2001
Stellar International Inc. Reports First Quarter Revenue and Gross Profit Increases
(read more)
December 5, 2000
Stellar International Inc. - Announcement
(read more)